ABOUT DEXCEL PHARMA USA
High Quality, Affordable Prescription Pharmaceutical Products from People that Care.
With a strong foundation in innovation and scientific excellence, we are dedicated to improving patient outcomes and enhancing lives.
A LEGACY OF INNOVATION, A FUTURE OF GLOBAL IMPACT
Dexcel Pharma USA has a long-standing commitment to delivering high-quality, affordable prescription pharmaceutical products. Formerly known as Edenbridge Pharmaceuticals, our company has built a reputation for trust, integrity, and innovation within the U.S. healthcare landscape.
In 2022, we were acquired by Dexcel Pharma, and in 2024 rebranded as Dexcel Pharma USA to align more closely with our global identity and long-term vision. Dexcel Pharma is the largest private pharmaceutical company in Israel, founded in 1968, and now providing pharmaceuticals to over 30 markets worldwide.
EXPLORE OUR PRODUCTS →
The History of DPU
While our name has changed, our dedication to advancing patient care and scientific excellence remains as strong as ever. This evolution reflects both our continued growth and our commitment to shaping a healthier tomorrow.
The Culture of DPU
Our culture is rooted in purpose, collaboration, and care. As a close-knit, mission-driven team, we believe in supporting one another, valuing diverse perspectives, and maintaining a strong sense of responsibility to the patients who rely on our products.
We foster a workplace where integrity and passion thrive—because we know that the people behind the medicine are just as important as the medicine itself.
What we believe shapes how we lead — the principles that guide our work, our decisions, and our commitment to better health.
INTEGRITY
We uphold the highest standards of
ethics and transparency in all we do.
QUALITY
We are uncompromising in our pursuit of excellence in every product we carry.
COMMITMENT
We are deeply dedicated to health, well-being, and the communities we serve.
TRUST
We strive to be a reliable and consistent partner to
healthcare providers and patients.
INNOVATION
We embrace forward-thinking solutions grounded in
science and research.
Explore Our Products
Generic Products
Broad coverage across cardiology, neurology, gastroenterology, and more—our high-quality generics deliver consistent, trusted care for everyday and complex conditions alike.
Branded Products
Our portfolio set the standard in corticosteroid therapy for multiple myeloma—offering reliable outcomes backed by FDA approval and clinical confidence.
Specialty Products
Our portfolio of specialty pharmaceutical offerings targets rare, complex conditions—treating refractory seizures and Gaucher disease with precision and care.
With a focus on cutting-edge science and patient well-being, we are bringing better health and brighter futures to communities we serve.
Get in touch with our team to learn more about the exciting innovation happening today!
GET IN TOUCH WITH OUR TEAM →